Advances in Brain Tumor Therapy

Arun Kumar Singh holds an M.Pharm in Pharmaceutics from Galgotias University, India, and serves as an Assistant Professor in the Department of Pharmacy at Vivekanand Global University. He is actively engaged in teaching and interdisciplinary research spanning nano-formulation, artificial intelligence, machine learning, big data analytics, IoT, blockchain, cancer biology, and neuroscience.Mr. Singh has made substantial scholarly contributions, authoring one book with IOP Publishing, five book chapters with River Publishers, and 28 review articles in reputed journals, including high-impact publications in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer. In addition, he has authored and edited 58 books with leading publishers such as Elsevier, CRC Press, and Wiley. Known for his research acumen and leadership, Mr. Singh is committed to advancing pharmaceutical sciences through innovation and interdisciplinary collaboration, with a focus on impactful healthcare solutions.Prof. (Dr.) Rajwinder Kaur is the Assistant Dean of Pharm D (Academics) at Chitkara College of Pharmacy, Chitkara University, Punjab, India. With sixteen years of experience in teaching and research, she has held positions such as DST Women Scientist (WOS-A) at Punjab University, Chandigarh, and received prestigious fellowships like the CSIR-SRF and UGC-MRP. Dr. Kaur was awarded the "Dr. Harpal Singh Buttar and Harinder Kaur Buttar Young Scientist Award in Pharmaceutical Sciences for Rural Women" in 2013 and the Young Scientist Award "Women in Pharmaceutical Sciences" in 2023. Her research focuses on computational drug design, synthesis of fused-heterocyclic compounds, nanomedicine, and AI, particularly in inflammation, asthma, and neurological disorders. Dr. Kaur has published over 50 papers and 10 book chapters, and has edited a book. She is a senior member of the Hong Kong Chemical, Biological & Environmental Engineering Society (HKCBEES) and a life member of the Indian Pharmacy Graduate Association (IPGA). Dr. Thakur Gurjeet Singh is a pharmacology researcher with extensive graduate training in clinical and preclinical drug development. His work focuses on the neuroprotective mechanisms of pharmacological preconditioning in neurodegenerative disorders such as Alzheimer’s disease, Parkinsonism, stroke, epilepsy, and dementia. He has investigated key protective pathways involving adenosine, opioids, CGRP, calcium signaling, protein kinase-C, heat shock proteins, and MAP kinase. His research also explores novel therapeutic pathways using agents such as morphine and capsaicin, with additional expertise in mechanistic studies of substance dependence, including nicotine, alcohol, and morphine addiction. Dr. Singh’s core competencies include animal model development and validation, anesthetic and preconditioning techniques, histopathological analysis, and behavioral data evaluation. His broader interests include ALS, stem cell therapy, and movement disorders such as tardive dyskinesia.Dr. Ashutosh Pareek, Professor at Banasthali Vidyapith with over 15 years of experience in pharmaceutical sciences, holds gold medals for his Master's and Bachelor's degrees in Pharmacy. Dr. Pareek specializes in neuropharmacology and innovative drug delivery systems, focusing on neurodegenerative disorders, cancer, and autoimmune diseases. His research includes developing advanced drug delivery systems for immunomodulators like naringenin. Dr. Pareek leads a research team working on these critical health issues and has published over 45 research papers and authored five technical books. He holds an international formulation patent and has received numerous awards, including the Zee National Achievers Award 2023. His work is funded by national and international agencies such as ICMR, DST-SERB, DBT, the American Association of Pharmaceutical Scientists, and the International Brain Research Organization. He serves as a Review Editor for Frontiers in Pharmacology and Frontiers in Oncology and reviews for leading journals by Elsevier, Springer, and Bentham.Dr. Niraj Kumar Jha is an Assistant Professor of Biotechnology at Galgotias University, India, with prior research affiliations at Chitkara University and Sharda University. His scholarly contributions include 200+ articles and an edited book. He has an H-index exceeding 50, reflecting significant impact in the biomedical sciences. He is a Member of the Royal Society of Biology, London, and has been recognized among the World’s Top 2% Scientists by Elsevier and Stanford University. Dr. Jha serves as Associate Editor for the Journal of Alzheimer’s Disease and IET Nanobiotechnology and as an editorial board member for several international journals. His research focuses on molecular mechanisms underlying neurodegenerative, cancer, and cardiovascular diseases, with particular emphasis on cellular signaling pathways and the therapeutic potential of natural products and synthetic small molecules.Affiliations and expertiseGalgotias University, India

• 1. Introduction to Brain Tumors2. Molecular Pathogenesis of Brain Tumors3. Pharmacokinetics and Pharmacodynamics in Brain Tumor Treatment4. Conventional Chemotherapeutic Approaches for Brain Tumor Treatment5. Targeted Molecular Therapies for Brain Tumor6. Immunotherapy and Brain Tumors7. Epigenetic Therapies for Brain Tumor8. Nanotechnology and Drug Delivery Systems for Brain Tumor9. Stem Cells in Brain Tumor Therapy10. Harnessing Oxidative Stress: Novel Therapeutics in Pediatric Brain Cancer11. Advanced Imaging Techniques in Brain Tumor Diagnosis and Surgery12. Combination Therapies for Brain Therapy: Synergistic Approaches13. Decoding MGMT: Biochemistry, Drug Resistance, and Diagnostic Innovations14. Molecular Mechanisms of Drug Resistance in Brain Therapy15. Personalized Medicine in Brain Tumors16. Innovations and Obstacles in Pediatric Brain Cancer Therapy17. Clinical Trials and Regulatory Aspects for Brain Tumor Treatment18. Future Directions in Brain Tumor Therapy19. Case Studies and Real-World Applications